BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14596640)

  • 1. Pharmacogenetic aspects in treatment of colorectal cancer--an update.
    Stoehlmacher J; Goekkurt E; Lenz HJ
    Pharmacogenomics; 2003 Nov; 4(6):767-77. PubMed ID: 14596640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of colorectal cancer prevention and treatment.
    Nguyen H; Tran A; Lipkin S; Fruehauf JP
    Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics in chemotherapy of colorectal cancer.
    Henriette Tanja L; Guchelaar HJ; Gelderblom H
    Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring chemotherapy in advanced colorectal cancer.
    Park DJ; Stoehlmacher J; Lenz HJ
    Curr Opin Pharmacol; 2003 Aug; 3(4):378-85. PubMed ID: 12901946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of colorectal cancer.
    Marsh S
    Expert Opin Pharmacother; 2005 Dec; 6(15):2607-16. PubMed ID: 16316300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
    Al-Salama HM; Johnstone EC; Kerr DJ
    Discov Med; 2009 Oct; 8(42):104-7. PubMed ID: 19833054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic contribution to drug response.
    Watson RG; McLeod HL
    Cancer J; 2011; 17(2):80-8. PubMed ID: 21427551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and biomarkers in colorectal cancer.
    Strimpakos AS; Syrigos KN; Saif MW
    Pharmacogenomics J; 2009 Jun; 9(3):147-60. PubMed ID: 19381163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics and -genetics in colorectal cancer.
    Pohl A; Lurje G; Manegold PC; Lenz HJ
    Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biomarker for chemotherapy in patients with colorectal cancer].
    Matsusaka S
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.
    Cortejoso L; López-Fernández LA
    Pharmacogenomics; 2012 Jul; 13(10):1173-91. PubMed ID: 22909207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in colorectal cancer: a systematic review.
    Funke S; Brenner H; Chang-Claude J
    Pharmacogenomics; 2008 Aug; 9(8):1079-99. PubMed ID: 18681783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of genetic testing in the management of colorectal cancer.
    Stoehlmacher J; Lenz HJ
    Am J Pharmacogenomics; 2003; 3(2):73-88. PubMed ID: 12749725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
    Braun MS; Quirke P; Seymour MT
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):489-501. PubMed ID: 17428170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
    Milano G
    Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
    Russo A; Corsale S; Cammareri P; Agnese V; Cascio S; Di Fede G; Macaluso M; Bazan V
    J Cell Physiol; 2005 Sep; 204(3):742-9. PubMed ID: 15828025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using genetic variation to optimize cancer chemotherapy.
    McLeod HL; Papageorgio C; Watters JW
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.
    Kruzelock RP; Short W
    Curr Probl Cancer; 2007; 31(5):315-66. PubMed ID: 17905192
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive markers for colorectal cancer: current status and future prospects.
    Longley DB; McDermott U; Johnston PG
    Clin Colorectal Cancer; 2003 Feb; 2(4):223-30. PubMed ID: 12620141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.